Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 15 IN SODIUM CHLORIDE 0 45.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus POTASSIUM CHLORIDE 0 15 IN SODIUM CHLORIDE 0 45.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs POTASSIUM CHLORIDE 0.15% IN SODIUM CHLORIDE 0.45%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Potassium is the principal intracellular cation; it corrects hypokalemia and maintains cellular membrane potential. Sodium chloride provides sodium and chloride ions to maintain fluid balance and osmolarity.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion: Typically 10-20 mEq/h (max 40 mEq/h) with continuous ECG monitoring; rate not to exceed 1 mEq/min. Concentration: 0.15% KCl in 0.45% NaCl provides 2 mEq KCl per 100 mL. Administer via central line if concentration > 0.1%.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Not applicable as potassium is an electrolyte; its serum half-life depends on redistribution and renal function. In normal renal function, excess exogenous potassium is eliminated within hours; terminal elimination half-life is approximately 2-4 hours in healthy individuals but prolonged in renal impairment.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Renal: >90% of administered potassium is excreted by the kidneys, primarily via distal tubular secretion in the collecting duct. Fecal: <10% eliminated in feces. Biliary: negligible.
Category C
Category A/B
Electrolyte
Electrolyte